EGFR and Pleural effusion: In conclusion, the intrapleural administration of arsenic was able to reduce the amount of the pleural effusion, lighten the color of the pleural effusion, and diminish the number of tumor cells in the pleural effusion in NSCLC patients with various EGFR genotypes.